INS and gestational diabetes: The heterogeneous aetiology of GDM and associated risk factors, in concert with genetic predisposition and the degree to which individual patients can achieve glycaemic control and insulin secretory requirements, place miRNAs in an attractive position as clinically relevant targets, regulating multiple genes in diverse biological pathways46,47.